Name | Name of the executing authority | Project duration in months | Total amount of support, EUR |
Reflection of EMT processes in liquid biopsies for decision-making in pancreatic cancer treatment | LSMU | 36 | 150000.00 |
Analysis of the free circulating DNA mutation profile in the blood of healthy, atrophic gastritis and gastric cancer patients | LSMU | 18 | 60000.00 |
A study of personalised immunotherapy and local tumour cryotherapy in non-small cell lung cancer patients, assessing changes in peripheral blood T lymphocyte populations and functions | LSMUL Kaunas Clinic | 36 | 109070.00 |
Epigenetic biomarkers for early non-invasive diagnosis of renal tumours and personalised therapy | NSI and VU | 24 | 25800.00 |
Development of model systems for personalised therapy in endometrial cancer | VU | 36 | 100000.00 |
Diagnostic value of eosinophil-specific blood markers in asthma |
LSMU | 18 | 28000.00 |
Genetic biomarker analysis in patients with squamous cell laryngeal cancer |
LSMU | 24 | 60000.00 |
Molecular studies of CAR-NK cells in vitro and in vivo | VU | 36 | 70000.00 |
Necrotising enterocolitis of prematurity: multilevel metagenomic and proteomic biomarkers Study |
LSMU | 36 | 45000.00 |
An innovative approach to identify signalling pathways in pancreatic cancer and use it to tailor individual therapy with redistributed targeted therapies | VU | 24 | 55000.00 |
Exploring a personalised cardiovascular risk prediction model: using artificial intelligence and epigenetics | VU Santaros Clinic | 18 | 59000.00 |
Multigene marker system for prostate cancer risk detection | NVI | 12 | 39300.00 |
801170.00 |